摘要
目的:了解药品集中供应对单病种医疗费用的影响,对解决老百姓"看病贵"问题提供有效可行的建议。方法:选取老年性白内障、慢性泪囊炎、混合痔、慢性鼻窦炎4个病种,利用PASW Statistics18统计软件对药品集中供应改革前、后1年各病种病例平均住院总费用、药品费用、住院天数和住院床日费用等指标进行比较并进行统计学分析。结果与结论:与改革前比较,改革后4个病种的4项指标几乎都降低,分别为25·7%、71·5%、1·18d、2·9%,33·9%、70·3%、1·1d、21·7%,6·2%、18·9%、0·6d、3·7%,6·7%、41%、-0·88d、17·67%。药品集中供应可通过降低单病种药费实现患者总医疗费用的降低,但其推行需要国家调整有关政策、创新和完善相关机制、充分调动医务人员积极性等。
OBJECTIVE: To learn the effect of centralized drug supply on medical cost for single disease, so as to provide an effective and feasible solution for the problem of "high cost of getting medical service" faced by common people of the country. METHODS : The conditions of senile cataract, chronic dacryocystitis, mixed hemorrhoids and chronic sinusitis were selected as the study subject of single disease. For each single disease, the total hospitalization expense, drug expense, hospitalization stay, daily expense per bed before and 1 year after the implementation of centralized drug supply were calculated and tested statistically using the statistical software of PASW Statistics 18. RESULTS & CONCLUSIONS: After the implementation of centralized drug supply, the 4 indexes of 4 disease types has decreased nearly by 25.7%, 71.5%, 1.18 d, 2.9% ; 33.9%, 70.3%, 1.1 d, 21.7% ; 6.2%, 18.9%, 0.6 d, 3.7%; 6.7%, 41%, -0.88 d, 17.67%, respectively. Centralized drug supply can reduce total medical cost for patients through lowering drug expenses for single diseases. The deepening of the reform requires government to adjust relevant policies, innovate and perfect relevant mechanisms, so as to bring the initiative of medical staff into full play.
出处
《中国药房》
CAS
CSCD
2012年第21期1926-1928,共3页
China Pharmacy
关键词
药品集中供应
单病种费用
住院总费用
影响分析
Centralized drug supply
Single disease expense
Total hospitalization expense
Effect analysis